Explore our blogs on various markets

As a real estate investor or market analyst, one of your biggest challenges is identifying undervalued properties before the rest of the market catches on. . This becomes even harder in emerging markets, where data is often incomplete, pricing trends are inconsistent, and local insights are difficult to validate. Yet, these markets also offer some of the highest potential returns if approached with the right tools and strategy....

August 2, 2025 | Thousand Oaks, CA — Amgen has officially announced Meritide (formerly MariTide, maridebart cafraglutide), its groundbreaking investigational therapy for obesity, type 2 diabetes, and related cardiometabolic conditions, marking a bold step forward in the global fight against metabolic disease.. A breakthrough in obesity and diabetes management. In results from its Phase 2 clinical trial, Meritide showed strong and steady weight loss in adults living with obesity, both with and without type 2 diabetes...

Label expansion in the pharmaceutical and life sciences industry refers to the process of gaining regulatory approval to use an existing drug for new indications, patient groups, or treatment settings. It’s a critical growth path for companies aiming to maximize the value of approved therapies. . As an organization evaluating label expansion opportunities, you need more than just clinical trial data...

Eli Lilly has officially acquired Verve Therapeutics, a pioneering biotech company specializing in in vivo gene editing for cardiovascular disease. The deal, announced on July 25, 2025, is valued at up to $1.3 billion. . It includes an upfront cash payment of $10.50 per share and a contingent value right (CVR) that may provide an additional $3.00 per share if Verve’s lead candidate reaches a U.S...

On July 22, 2025, Sanofi announced a definitive agreement to acquire Vicebio, a clinical-stage biotechnology company developing next-generation respiratory vaccines. The deal is valued at $1.6 billion and includes a $1.15 billion upfront payment with up to $450 million in milestone-based payments. The acquisition aims to expand Sanofi’s respiratory vaccine portfolio through access to Vicebio’s proprietary Molecular Clamp technology....

Clinical development is a long and expensive process. It often takes years of planning, testing, and data collection to bring a new medicine to market. Even then, most clinical trials do not succeed...

Clinical trials help test if new medicines are safe and effective. But many trials fail to find enough people or keep them until the end. One reason is that trial designs often do not match what patients need or want....

Generative AI is transforming the way pharmaceutical companies operate. It helps teams discover drugs faster, write documents quicker, and find insights in huge amounts of data. Instead of doing everything manually, experts can now use GenAI to save time and focus on what matters most—patient care and innovation....

Summary:. Roche, one of the world’s biggest drugmakers, is thinking about selling its medicines directly to patients in the United States. The company’s CEO, Thomas Schinecker, said this plan could help reduce the high cost of prescription drugs in the country...

Roivant Sciences is developing brepocitinib, a new oral drug that blocks both TYK2 and JAK1. These proteins play a key role in autoimmune diseases like dermatomyositis and lupus. . Brepocitinib targets several harmful signals in the body, not just one, which may make it more effective than older treatments...

Summary. Roche has officially initiated the global rollout of Lunsumio® (mosunetuzumab) for the treatment of adult patients with third-line and beyond relapsed or refractory follicular lymphoma (FL). The fixed-duration, off-the-shelf, T-cell engaging bispecific antibody has already been commercially used in over 2,400 patients, according to company data, with significant adoption across major oncology markets....

Zomedica Pharmaceuticals has released a new and improved canine cortisol assay for its TRUFORMA point-of-care diagnostic platform. . The assay allows veterinarians to diagnose Cushing’s syndrome and Addison’s disease within minutes, using a simple in-clinic process. . Previously, such diagnoses required shipping blood samples to external labs and waiting one or two days for results...

Discover the top 5 generative AI tools transforming drug discovery with faster molecule design, target prediction, and real-world pharma applications.. Generative AI has almost transformed how drug discovery works today. In the last five years, it has gone from being a research experiment to a practical tool used by biotech firms and pharmaceutical companies around the world. ...

The market for generic immunology drugs in the Asia-Pacific (APAC) region is witnessing rapid expansion, driven by increasing healthcare access, rising chronic disease prevalence, and cost-containment measures by governments. . As more biologics go off-patent, pharma companies are moving quickly to introduce affordable generic and biosimilar alternatives across key APAC markets.. If you are planning to enter or expand in this space, pricing is one of the most critical levers for success...

What should a business really look for to know if they’ve hit product-market fit? While businesses often rely on gut feeling or customer praise, that’s not enough. . The aim should be to measure product-market fit with real data, not just assumptions. We would look at proven ways to track how well your product is solving a real problem for a real market...

In 2025, the pharmaceutical industry is seeing major changes in drug development, pricing, and delivery. AI is speeding up R&D, GLP-1 drugs are redefining obesity treatment, and precision medicine is becoming standard. . This guide breaks down the top trends shaping pharma this year, with real examples and their impact on healthcare and business....

Artificial Intelligence (AI) is changing modern healthcare by helping doctors make faster, smarter decisions. From diagnosing diseases to personalizing treatments and reducing paperwork, AI is making care more accurate and efficient. . With the global AI healthcare market expected to reach nearly $96 billion by 2033, it's clear that AI is no longer just a future trend—it’s a key part of today’s medical systems. ...

AI is changing how we discover new medicines. Instead of testing each idea in a lab, AI studies massive medical data to quickly find the most promising drug candidates. . This speeds up research, lowers costs, and improves success rates...

Market research is evolving, and generative AI is at the heart of this transformation. Whether you’re trying to understand customer behavior, test a new product idea, or analyze open-ended feedback, Gen AI can help you do it faster and more efficiently. . It doesn’t just crunch numbers; it helps you think, explore, and create...

Several large language models (LLMs) are already being used or evaluated by pharmaceutical companies and health tech teams. From accelerating drug discovery to streamlining regulatory submissions and enhancing patient education, LLMs are redefining how life sciences teams work with data, documents, and decisions.. Unlike traditional AI systems, LLMs can read, understand, and generate natural language at scale, making them ideal for navigating the complexity of biomedical literature, clinical protocols, compliance guidelines, and real-world evidence....

Generative AI is helping doctors and scientists design personalized medicine faster and more accurately. These AI tools use medical, genetic, and clinical data to create treatment plans, drugs, and predictions that match an individual’s unique biology.. Researchers and biotech companies are now using generative AI (GenAI) models to improve patient care...

AI and ML imaging tools are now central to drug discovery. These systems process cell images to detect drug effects, predict safety, and optimize compounds. In this news article, you will find how AI and ML-based imaging are reshaping drug discovery in 2025....

Regulatory impact assessment (RIA) is an essential step for ensuring pharmaceutical product compliance, quality, and safety whenever changes occur in products or their manufacturing processes. However, this process has traditionally been complex and time-consuming, with risks of delaying product availability and increasing regulatory workload.. Today, Generative AI (GenAI) is rapidly changing this landscape, presenting new opportunities for efficiency and accuracy across global pharma operations....

It processes over one thousand interactions per week on cloud infrastructure, making high-precision ligand binding calculations available through a user-friendly interface.. How XFEP Works with High‑Precision Physics and AI‑Driven Modeling. Physics‑Driven Free Energy Perturbation Enables Accurate Binding Predictions...

What should a business really look for to know if they’ve hit product-market fit? While businesses often rely on gut feeling or customer praise, that’s not enough. .  . The aim should be to measure product-market fit with real data, not just assumptions...

FHD-909: Pioneering SMARCA2 Inhibition in Oncology – Market Analysis by ConsainsightsFoghorn Therapeutics has announced the development of FHD-909, a first-in-class oral SMARCA2 inhibitor designed to exploit synthetic lethality in cancer driven by SMARCA4 mutations. As a highly selective SMARCA2 inhibitor, FHD-909 stands at the forefront of precision oncology, targeting chromatin remodeling pathways that have been validated as critical vulnerabilities in various tumor types. According to a recent oncology market analysis by Consainsights, FHD-909: Pioneering SMARCA2 Inhibition in Oncology – Market Analysis by Consainsights underscores a multi-billion-dollar market potential, reflecting the growing demand for targeted cancer therapies with robust efficacy and safety profiles.Mechanism of Action and Scientific RationaleFHD-909 operates by selectively inhibiting the ATPase activity of SMARCA2, a key catalytic subunit of the SWI/SNF chromatin remodeling complex...

Pharmaceutical market research helps you make smarter, data-driven decisions across drug development, clinical trials, and market access. . It uncovers unmet needs, benchmarks competitors, and guides pricing and positioning—so you reduce risk and increase ROI. . Whether you're launching a new therapy or expanding into a new region, this guide shows how to turn real-world insights into strategic advantage....

Why do some beauty brands go viral while others barely make a mark? The answer often lies in market research. Behind every breakout skincare launch or cult-favorite lipstick is a deep understanding of what consumers crave, where gaps exist, and how trends are shifting. . If you're in the cosmetics space, guessing won't cut it...

Healthcare market research helps you understand what patients need, how providers operate, and where the market is heading. . From rising demand for digital health to shifting care models, it reveals real trends, not guesses. . Whether you're launching a new drug, expanding to a new region, or selling to hospitals, research gives you the data to move smartly. ...

Ever wondered why some fabrics fly off the shelves while others barely get noticed? It’s not just luck, it’s smart research. . In the textile world, tastes change fast, and every market plays by its own rules. That’s why guessing what to make or where to sell it can cost you. ...

Thinking of starting your own snacks brand?. The snacks market is massive, fast-moving, and full of opportunities. If you have a unique idea or product, you're already one step ahead...

Meta has created Llama 4. as its latest open-source AI model. Unlike older models, Llama 4 comes with...

Are you planning to launch a brand-new toy that you believe will be a massive hit. You’ve spent months perfecting its design, choosing the right colors, and packaging it to perfection. . But when it finally reaches stores, it doesn’t sell...

Market research helps online businesses understand customers, competitors, and trends to make smart choices. If you're launching a new product or growing your store, research helps you find the right audience, set good prices, and stay ahead of competitors. . This guide will show you simple steps to gather and use market data....

Gen Z is the name everyone talks about. You hear about them in podcasts, social media, and even casual conversations. Brands, marketers, and businesses are all trying to understand them...

The D2C market is growing rapidly as more brands choose to sell directly to consumers, bypassing traditional retail channels. With increasing competition and changing consumer preferences, entering this space without proper market research can be risky. Understanding your audience, competitors, and pricing dynamics is crucial for building a successful D2C brand....

If you’re looking to start a clothing brand or scale your existing one, you’re in the right place. . Market research is the foundation of a successful fashion business—it helps you understand your target audience, identify trends, analyze competitors, and make data-driven decisions that set your brand apart.. At Consainsights, we have worked with over 20 clothing brands, helping them navigate the complexities of market research and make informed business moves...

The way businesses are making decisions today has changed. Guesswork and assumptions no longer cut it in a competitive market. Whether you’re launching a new product, expanding to a new market, or trying to understand customer behavior, market research is the difference between making a smart move and taking a blind risk....

Looking to find the best market research companies in 2025? . Here’s your guide to the top 14 firms that are shaping the future of. business insights. ...

Market research is a crucial activity for any organization, whether you're a small startup or a large corporation. It helps businesses understand their target audience, stay ahead of trends, and make data-driven decisions. . At Consainsights, after working with hundreds of clients and researching over 10,000+ markets, we have refined a strategic approach to market research...

As a leading market research company, we have helped 100+ enterprise organizations perform custom market research for different industries.. So, our team created this list of useful market research tools after using effectively.. Let’s get started....

Starting a new business is exciting, but before diving headfirst into investment and scaling, one crucial step often gets overlooked—market research. This foundational process not only helps validate your startup idea but also significantly increases your chances of success. Understanding the market, your potential customers, and the competitive landscape can guide your decisions and save you from costly mistakes down the road.In this article, we’ll walk you through a complete step-by-step process for conducting market research tailored specifically for startups. But before we dive into the how-to, let’s first explore why market research is so important in the early stages of your entrepreneurial journey.Why You Should Invest In Market Research For Your Startup?By gathering valuable insights into your target audience, competitors, and industry trends, you can make informed decisions that drive growth and mitigate risks.Let’s take a look at some of the major reasons why market research is a must for your startup’s success.1...

Market research is the backbone of any successful business strategy. It provides invaluable insights into consumer behavior, market trends, and the competitors. By understanding these factors, businesses can make informed decisions that drive growth and profitability.In recent years, we've had the privilege of assisting over 100+ businesses with their market research needs...